{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:47Z","timestamp":1792783427226,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Universit\u00e9 Paris-Saclay","id":[{"id":"https:\/\/ror.org\/03xjwb503","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s40264-026-01689-z","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:13:34Z","timestamp":1786630414000},"page":"1493-1504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phloroglucinol Exposure During Early Pregnancy and Risk of Major Congenital Malformations: A Nationwide Cohort Study in France"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1156-9289","authenticated-orcid":false,"given":"Antoine","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Weill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8687-9092","authenticated-orcid":false,"given":"Antoine","family":"Rachas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4232-5140","authenticated-orcid":false,"given":"Perrine","family":"Capmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7646-3667","authenticated-orcid":false,"given":"Rosemary","family":"Dray-Spira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"1689_CR1","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00228-018-2416-6","volume":"74","author":"C Blanchard","year":"2018","unstructured":"Blanchard C, Pouchain D, Vanderkam P, Perault-Pochat M-C, Boussageon R, Vaillant-Roussel H. Efficacy of phloroglucinol for treatment of abdominal pain: a systematic review of literature and meta-analysis of randomised controlled trials versus placebo. Eur J Clin Pharmacol. 2018;74:541\u20138. https:\/\/doi.org\/10.1007\/s00228-018-2416-6.","journal-title":"Eur J Clin Pharmacol"},{"key":"1689_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00228-019-02745-7","volume":"76","author":"C Blanchard","year":"2020","unstructured":"Blanchard C, Vanderkam P, Pouchain D, Mignot S, Vaillant H-R, Boussageon R. Efficacy of phloroglucinol for the treatment of pain of gynaecologic or obstetrical origin: a systematic review of literature of randomised controlled trials. Eur J Clin Pharmacol. 2020;76:1\u20136. https:\/\/doi.org\/10.1007\/s00228-019-02745-7.","journal-title":"Eur J Clin Pharmacol"},{"key":"1689_CR3","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.ajem.2009.04.030","volume":"28","author":"H Boubaker","year":"2010","unstructured":"Boubaker H, Boukef R, Claessens Y-E, Bouida W, Grissa MH, Beltaief K, et al. Phloroglucinol as an adjuvant analgesic to treat renal colic. Am J Emerg Med. 2010;28:720\u20133. https:\/\/doi.org\/10.1016\/j.ajem.2009.04.030.","journal-title":"Am J Emerg Med"},{"key":"1689_CR4","volume-title":"Pilules roses: de l\u2019ignorance en m\u00e9decine","author":"J Ferry-Danini","year":"2023","unstructured":"Ferry-Danini J. Pilules roses: de l\u2019ignorance en m\u00e9decine. Paris: Stock; 2023."},{"key":"1689_CR5","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1365-2036.2007.03296.x","volume":"25","author":"O Chassany","year":"2007","unstructured":"Chassany O, Bonaz B, Bruley Des Varannes S, Bueno L, Cargill G, Coffin B, et al. Acute exacerbation of pain in irritable bowel syndrome: efficacy of phloroglucinol\/trimethylphloroglucinol\u2014a randomized, double\u2010blind, placebo\u2010controlled study. Aliment Pharmacol Ther. 2007;25:1115\u201323. https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03296.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"1689_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5056\/jnm19160","volume":"26","author":"SY Shin","year":"2020","unstructured":"Shin SY, Cha BK, Kim W-S, Park JY, Kim JW, Choi CH. The effect of phloroglucinol in patients with diarrhea-predominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Neurogastroenterol Motil. 2020;26:117\u201327. https:\/\/doi.org\/10.5056\/jnm19160.","journal-title":"J Neurogastroenterol Motil."},{"key":"1689_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12013-013-9782-6","volume":"69","author":"W Fu","year":"2014","unstructured":"Fu W, Yao J, Li Q, Wang Y, Wu X, Zhou Z, et al. Efficacy and safety of parecoxib\/phloroglucinol combination therapy versus parecoxib monotherapy for acute renal colic: a randomized, double-blind clinical trial. Cell Biochem Biophys. 2014;69:157\u201361. https:\/\/doi.org\/10.1007\/s12013-013-9782-6.","journal-title":"Cell Biochem Biophys"},{"key":"1689_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.contraception.2009.07.009","volume":"81","author":"Y Zhuang","year":"2010","unstructured":"Zhuang Y, Zhu X, Huang L-L. The effect of phloroglucinol on pain in first-trimester surgical abortion: a double-blind randomized controlled study. Contraception. 2010;81:157\u201360. https:\/\/doi.org\/10.1016\/j.contraception.2009.07.009.","journal-title":"Contraception"},{"issue":"1","key":"1689_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245854","volume":"16","author":"A Meyer","year":"2010","unstructured":"Meyer A, Fermaut M, Drouin J, Carbonnel F, Weill A. Drug use for gastrointestinal symptoms during pregnancy: a French nationwide study 2010\u20132018. PLoS ONE. 2010;16(1):e0245854. https:\/\/doi.org\/10.1371\/journal.pone.0245854.","journal-title":"PLoS ONE"},{"key":"1689_CR10","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.gyobfe.2011.07.013","volume":"39","author":"I Lacroix","year":"2011","unstructured":"Lacroix I, Hurault-Delarue C, Kessler S, Guitard C, Vidal S, Albouy-Cossard C, et al. Premi\u00e8res donn\u00e9es \u00e9pid\u00e9miologiques sur le phloroglucinol et exposition au cours du premier trimestre de grossesse. Gyn\u00e9cologie Obst\u00e9trique Fertil. 2011;39:694\u20137. https:\/\/doi.org\/10.1016\/j.gyobfe.2011.07.013.","journal-title":"Gyn\u00e9cologie Obst\u00e9trique Fertil."},{"key":"1689_CR11","unstructured":"ANSM (Agence Nationale de Securit\u00e9 du M\u00e9dicament). Utilisation du Phloroglucinol\u202f: chez la femme enceinte [Internet]. 2020 Oct. https:\/\/ansm.sante.fr\/uploads\/2021\/09\/30\/20201006-cr-csp-rga.pdf. Accessed 12 Oct 2025."},{"key":"1689_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2025.01.008","author":"A Meyer","year":"2025","unstructured":"Meyer A, Marty L, Drouin J, Weill A, Carbonnel F, Dray-Spira R. Risks of 75 major congenital malformations after in utero exposure to thiopurines and anti-TNF for maternal inflammatory bowel disease. Clin Gastroenterol Hepatol. 2025. https:\/\/doi.org\/10.1016\/j.cgh.2025.01.008.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1689_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004576","volume":"22","author":"A Tran","year":"2025","unstructured":"Tran A, Zureik M, Sibiude J, Miranda S, Drouin J, Marty L, et al. First-trimester exposure to macrolides and risk of major congenital malformations compared with amoxicillin: a French nationwide cohort study. PLoS Med. 2025;22:e1004576. https:\/\/doi.org\/10.1371\/journal.pmed.1004576.","journal-title":"PLoS Med"},{"key":"1689_CR14","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1001\/jamapediatrics.2023.2900","volume":"177","author":"M Lassalle","year":"2023","unstructured":"Lassalle M, Zureik M, Dray-Spira R. Proton pump inhibitor use and risk of serious infections in young children. JAMA Pediatr. 2023;177:1028. https:\/\/doi.org\/10.1001\/jamapediatrics.2023.2900.","journal-title":"JAMA Pediatr"},{"key":"1689_CR15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.38039","volume":"8","author":"C Bernard","year":"2025","unstructured":"Bernard C, Duchemin T, Marty L, Drouin J, Miranda S, Semenzato L, et al. First-Trimester mRNA COVID-19 Vaccination and Risk of Major Congenital Anomalies. JAMA Netw Open. 2025;8:e2538039. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.38039.","journal-title":"JAMA Netw Open"},{"key":"1689_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-27935-3","volume":"13","author":"N Al-Dewik","year":"2023","unstructured":"Al-Dewik N, Samara M, Younes S, Al-jurf R, Nasrallah G, Al-Obaidly S, et al. Prevalence, predictors, and outcomes of major congenital anomalies: a population-based register study. Sci Rep. 2023;13:2198. https:\/\/doi.org\/10.1038\/s41598-023-27935-3.","journal-title":"Sci Rep"},{"key":"1689_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/OGX.0000000000000405","volume":"72","author":"BS Harris","year":"2017","unstructured":"Harris BS, Bishop KC, Kemeny HR, Walker JS, Rhee E, Kuller JA. Risk factors for birth defects. Obstet Gynecol Surv. 2017;72:123\u201335. https:\/\/doi.org\/10.1097\/OGX.0000000000000405.","journal-title":"Obstet Gynecol Surv"},{"key":"1689_CR18","unstructured":"EUROCAT. European Platform on Rare Disease Registration [Internet]. 2023 Nov. https:\/\/eu-rd-platform.jrc.ec.europa.eu\/eurocat\/eurocat-data\/prevalence_en. Accessed 29 Jan 2024."},{"key":"1689_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/bcp.70582","author":"T Duchemin","year":"2026","unstructured":"Duchemin T, Marty L, Drouin J, Miranda S, Botton J, Oli\u00e9 V, et al. Identification of major congenital malformations based on healthcare databases in France: a proof\u2010of\u2010concept study using the epi\u2010meres nationwide mother\u2013child register. Br J Clin Pharmacol. 2026. https:\/\/doi.org\/10.1002\/bcp.70582.","journal-title":"Br J Clin Pharmacol"},{"key":"1689_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1001\/jamapsychiatry.2025.3874","volume":"83","author":"K Fung","year":"2026","unstructured":"Fung K, Straub L, Bateman BT, Hernandez-Diaz S, Brill G, Zhu Y, et al. Z-Drug use in the first trimester of pregnancy and risk of congenital malformations. JAMA Psychiat. 2026;83:162. https:\/\/doi.org\/10.1001\/jamapsychiatry.2025.3874.","journal-title":"JAMA Psychiat"},{"key":"1689_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jamapsychiatry.2022.4109","volume":"80","author":"KF Huybrechts","year":"2023","unstructured":"Huybrechts KF, Straub L, Karlsson P, Pazzagli L, Furu K, Gissler M, et al. Association of in utero antipsychotic medication exposure with risk of congenital malformations in Nordic countries and the US. JAMA Psychiat. 2023;80:156. https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.4109.","journal-title":"JAMA Psychiat"},{"key":"1689_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n102","author":"BT Bateman","year":"2021","unstructured":"Bateman BT, Hernandez-Diaz S, Straub L, Zhu Y, Gray KJ, Desai RJ, et al. Association of first trimester prescription opioid use with congenital malformations in the offspring: population based cohort study. BMJ. 2021. https:\/\/doi.org\/10.1136\/bmj.n102.","journal-title":"BMJ"},{"key":"1689_CR23","doi-asserted-by":"publisher","first-page":"359.e1","DOI":"10.1016\/j.ajog.2013.10.880","volume":"210","author":"LD Botto","year":"2014","unstructured":"Botto LD, Panichello JD, Browne ML, Krikov S, Feldkamp ML, Lammer E, et al. Congenital heart defects after maternal fever. Am J Obstet Gynecol. 2014;210:359.e1-359.e11. https:\/\/doi.org\/10.1016\/j.ajog.2013.10.880.","journal-title":"Am J Obstet Gynecol"},{"key":"1689_CR24","doi-asserted-by":"publisher","first-page":"e674","DOI":"10.1542\/peds.2013-3205","volume":"133","author":"JW Dreier","year":"2014","unstructured":"Dreier JW, Andersen A-MN, Berg-Beckhoff G. Systematic review and meta-analyses: fever in pregnancy and health impacts in the offspring. Pediatrics. 2014;133:e674\u201388. https:\/\/doi.org\/10.1542\/peds.2013-3205.","journal-title":"Pediatrics"},{"key":"1689_CR25","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/uog.26224","volume":"61","author":"JS Carvalho","year":"2023","unstructured":"Carvalho JS, Axt\u2010Fliedner R, Chaoui R, Copel JA, Cuneo BF, Goff D, et al. ISUOG practice guidelines (updated): fetal cardiac screening. Ultrasound Obstet Gynecol. 2023;61:788\u2013803. https:\/\/doi.org\/10.1002\/uog.26224.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1689_CR26","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/j.1471-0528.2006.01050.x","volume":"113","author":"J Ouahba","year":"2006","unstructured":"Ouahba J, Luton D, Vuillard E, Garel C, Gressens P, Blanc N, et al. Prenatal isolated mild ventriculomegaly: outcome in 167 cases. BJOG Int J Obstet Gynaecol. 2006;113:1072\u20139. https:\/\/doi.org\/10.1111\/j.1471-0528.2006.01050.x.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"1689_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ejogrb.2020.03.016","volume":"248","author":"D Visconti","year":"2020","unstructured":"Visconti D, Neri C, De Santis M, Sabusco GP, Gratta M, Campagna G, et al. Recurrent miscarriage and fetal congenital malformations: is there a neglected causal association? Eur J Obstet Gynecol Reprod Biol. 2020;248:233\u20137. https:\/\/doi.org\/10.1016\/j.ejogrb.2020.03.016.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1689_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1471-0528.2009.02427.x","volume":"117","author":"L Saraswat","year":"2010","unstructured":"Saraswat L, Bhattacharya S, Maheshwari A, Bhattacharya S. Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review. BJOG An Int J Obstet Gynaecol. 2010;117:245\u201357. https:\/\/doi.org\/10.1111\/j.1471-0528.2009.02427.x.","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"1689_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jeph.2024.202373","volume":"72","author":"L Marty","year":"2024","unstructured":"Marty L, Miranda S, Weill A, Dray-Spira R. Pr\u00e9valence des malformations cong\u00e9nitales majeures en France entre 2010 et 2021. J Epidemiol Popul Health. 2024;72:202373. https:\/\/doi.org\/10.1016\/j.jeph.2024.202373.","journal-title":"J Epidemiol Popul Health."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-026-01689-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-026-01689-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-026-01689-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:42:59Z","timestamp":1792039379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-026-01689-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1689"],"URL":"https:\/\/doi.org\/10.1007\/s40264-026-01689-z","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Antoine Meyer: no competing interest. Alain Weill: no competing interest. Antoine Rachas: no competing interest. Perrine Capmas: no competing interest. Rosemary Dray-Spira: no competing interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EPI-PHARE has permanent access to the SNDS database in application of the provisions of Articles R. 1461-12\n                      et seq\n                      . of the French Public Health Code and French data protection authority decision CNIL-2016-316 (study registration number T-2025-04-571). Therefore, no informed consent was required. This study was performed in accordance with the Declaration of Helsinki (1964) and its subsequent amendments.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors had access to the SNDS database in application of the provisions of Articles R. 1461-12\n                      et seq\n                      . of the French Public Health Code and the French data protection authority decision CNIL-2016-316. Future researchers can request access via the Health data hub: (\n                      \n                      ).","order":3,"name":"Ethics","label":"Availability of Data","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Statistical code is not publicly available but may be provided upon reasonable request.","order":4,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study concept: Rosemary Dray-Spira; acquisition of data: Antoine Meyer; statistical analysis and interpretation of data: Antoine Meyer, Alain Weill, Rosemary Dray-Spira; drafting of the manuscript: Antoine Meyer; critical revision of the manuscript for important intellectual content: all authors; study supervision: Alain Weill and Rosemary Dray-Spira; accessed and verified the source data: Antoine Meyer, Alain Weill, Rosemary Dray-Spira; guarantor of the article: Rosemary Dray-Spira.\u00a0All authors read and approved the final version.","order":5,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EPI-PHARE has permanent access to the SNDS database in application of the provisions of Articles R. 1461-12 et seq. of the French Public Health Code and French data protection authority decision CNIL-2016-316 (study registration number T-2025-04-571). Therefore, no informed consent was required.","order":6,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EPI-PHARE has permanent access to the SNDS database in application of the provisions of Articles R. 1461-12 et seq. of the French Public Health Code and French data protection authority decision CNIL-2016-316 (study registration number T-2025-04-571). Therefore, no informed consent was required.","order":7,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}